查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612150

Aminoglycosides市場：依產品、給藥途徑和應用 - 2025-2030 年全球預測

Aminoglycosides Market by Product (Amikacin, Gentamicin, Kanamycin), Route of Administration (Injectables, Oral, Topical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Aminoglycosides市值為19.3億美元，預計2024年將達20.2億美元，複合年成長率為4.76%，預計2030年將達26.7億美元。

Aminoglycosides是一種抗生素，用於治療主要由革蘭氏陰性菌引起的嚴重細菌感染疾病。它在醫學領域的重要性在於它可以有效治療敗血症和結核病等危及生命的感染疾病，尤其是在其他抗生素無效的情況下。Aminoglycosides藥物的應用涵蓋人類醫學和獸醫學，在牲畜保健、確保食品安全和預防疾病爆發方面發揮重要作用。最終用途包括醫院、診所、研究機構和藥品製造。Aminoglycosides市場受到抗生素抗藥性增加等因素的影響，凸顯了對有效治療的需求，推動了市場需求。此外，新興國家細菌感染疾病的增加也提供了巨大的成長潛力。然而，市場面臨挑戰，例如嚴格的法律規範以及與過度使用相關的潛在毒性（例如腎毒性和耳毒性）。探索潛力，開發減少副作用、提高療效的Aminoglycosides衍生物還有相當大的創新空間。專注於聯合治療以減少抗藥性發展的研發投資可能會進一步推動市場成長。此外，市場相關人員應探索與生技公司合作，開發可提高Aminoglycosides使用精確度的藥物輸送系統。主要發展包括高昂的開發成本和冗長的核准流程，這對新進入者構成了威懾。然而，政府對抗生素抗藥性研究的激勵和資助可能會減輕財務負擔。個人化醫療的趨勢提供了一條市場擴張之路，因為抗生素可以根據個別患者的需求進行客製化，從而有可能最佳化治療結果。市場競爭是研究主導的，為優先考慮創新和策略聯盟的公司創造了機會。

主要市場統計
基準年[2023] 19.3億美元
預測年份 [2024] 20.2億美元
預測年份 [2030] 26.7億美元
複合年成長率（%） 4.76%

市場動態：揭示快速發展的Aminoglycosides市場的關鍵市場洞察

供需的動態交互作用正在改變Aminoglycosides市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對革蘭氏陰性病菌感染有效治療的需求不斷增加
    • 使用動物用藥品治療動物感染疾病
  • 市場限制因素
    • Aminoglycosides開發與生產的複雜性
  • 市場機會
    • Aminoglycosides藥物遞送系統的進展
    • Aminoglycosides抗藥性機制的研究進展
  • 市場挑戰
    • Aminoglycosides的副作用和毒性

波特五力：駕馭Aminoglycosides市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Aminoglycosides市場的外部影響

外部宏觀環境因素在塑造Aminoglycosides市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解Aminoglycosides市場的競爭狀況

對Aminoglycosides市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣Aminoglycosides市場供應商的績效評估

FPNV定位矩陣是評估Aminoglycosides市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了Aminoglycosides市場的成功之路

Aminoglycosides市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對革蘭氏陰性菌感染疾病的有效治療方法的需求日益成長
      • 獸藥在治療動物感染疾病的應用
    • 抑制因素
      • Aminoglycosides開發與生產的複雜性
    • 機會
      • Aminoglycosides藥物遞送系統的進展
      • Aminoglycosides抗藥性機制的研究進展
    • 任務
      • Aminoglycosides的副作用和毒性
  • 市場區隔分析
    • 產品：慶大霉素，廣泛用於治療血液、腹部、肺部、皮膚和軟組織感染疾病。
    • 應用：Aminoglycosides藥物用於治療整體呼吸系統疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Aminoglycosides市場：依產品

  • Amikacin
  • 慶大霉素
  • 卡那黴素
  • 新黴素
  • Paromomycin
  • 鏈黴素
  • 妥布黴素

第7章Aminoglycosides市場：依給藥途徑分類

  • 注射
  • 口服
  • 話題

第8章Aminoglycosides市場：依應用分類

  • 呼吸系統疾病
  • 皮膚感染疾病
  • 尿道感染及骨盆腔疾病
  • 獸醫學

第9章美洲Aminoglycosides市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太Aminoglycosides市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲Aminoglycosides市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Cipla Limited 在印度推出用於治療進行性尿道感染的 plazomicin
    • Aminoglycosides抗生素的創新可提高安全性：降低聽力損失的風險
    • BDR Pharmaceuticals 推出尼洛替尼，一種治療罕見兒童和成人白血病的新方法
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • AstraZeneca plc
  • Bristol Myers Squibb Company
  • Cipla Limited
  • GlaxoSmithKline plc
  • Hangzhou Uniwise International Co., Ltd.
  • HuvePharma
  • Insmed Incorporated
  • Jiangxi Bolai Pharmacy Co., Ltd.
  • Kremoint Pharma Pvt. Ltd
  • Medico Remedies Pvt. Ltd.
  • Medson Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Vega Pharma Ltd.
  • Zoetis Inc.
Product Code: MRR-5D693B46C82A

The Aminoglycosides Market was valued at USD 1.93 billion in 2023, expected to reach USD 2.02 billion in 2024, and is projected to grow at a CAGR of 4.76%, to USD 2.67 billion by 2030.

Aminoglycosides are a class of antibiotics used primarily to treat severe bacterial infections, particularly those caused by gram-negative bacteria. Their importance in the medical field stems from their effectiveness in treating life-threatening infections like sepsis and tuberculosis, especially when other antibiotics fail. The application of aminoglycosides spans human and veterinary medicine, where they play a crucial role in livestock healthcare, ensuring food safety, and the prevention of disease outbreaks. The end-use scope extends to hospitals, clinics, research institutions, and pharmaceutical manufacturing. The market for aminoglycosides is influenced by factors such as rising antibiotic resistance, which underscores the necessity for effective treatments and drives market demand. Additionally, the growing incidences of bacterial infections in emerging economies provide significant growth potential. However, the market faces challenges from stringent regulatory frameworks and the potential for toxicity associated with overuse, such as nephrotoxicity and ototoxicity. Exploring potential opportunities, there is considerable room for innovation in developing aminoglycoside derivatives with reduced side effects and enhanced efficacy. Investment in research focused on combination therapies that reduce resistance development can further propel market growth. Moreover, market players should explore joint ventures with biotechnological firms to advance drug delivery systems that enhance the precision of aminoglycoside usage. Key limitations include the high cost of development and the lengthy approval process, which can deter new entrants. However, government incentives and funding for antibiotic resistance research may alleviate some financial burdens. Trends toward personalized medicine present an avenue for market expansion, as tailoring antibiotics to individual patient needs could optimize therapeutic outcomes. The nature of the aminoglycosides market is competitive and research-driven, presenting opportunities for enterprises that prioritize innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 1.93 billion
Estimated Year [2024] USD 2.02 billion
Forecast Year [2030] USD 2.67 billion
CAGR (%) 4.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aminoglycosides Market

The Aminoglycosides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in need for effective treatments for gram-negative bacterial infections
    • Utilization veterinary medicine to treat infections in animals
  • Market Restraints
    • Complexities in development and manufacturing of aminoglycosides
  • Market Opportunities
    • Advancements in drug delivery systems for aminoglycosides
    • Research and development into aminoglycoside resistance mechanisms
  • Market Challenges
    • Side effects and toxicity caused due to aminoglycosides

Porter's Five Forces: A Strategic Tool for Navigating the Aminoglycosides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aminoglycosides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aminoglycosides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aminoglycosides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aminoglycosides Market

A detailed market share analysis in the Aminoglycosides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aminoglycosides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aminoglycosides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aminoglycosides Market

A strategic analysis of the Aminoglycosides Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aminoglycosides Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bristol Myers Squibb Company, Cipla Limited, GlaxoSmithKline plc, Hangzhou Uniwise International Co., Ltd., HuvePharma, Insmed Incorporated, Jiangxi Bolai Pharmacy Co., Ltd., Kremoint Pharma Pvt. Ltd, Medico Remedies Pvt. Ltd., Medson Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Vega Pharma Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aminoglycosides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Amikacin, Gentamicin, Kanamycin, Neomycin, Paromomycin, Streptomycin, and Tobramycin.
  • Based on Route of Administration, market is studied across Injectables, Oral, and Topical.
  • Based on Application, market is studied across Respiratory Diseases, Skin Infection, UTI & Pelvic Diseases, and Veterinary Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in need for effective treatments for gram-negative bacterial infections
      • 5.1.1.2. Utilization veterinary medicine to treat infections in animals
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in development and manufacturing of aminoglycosides
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in drug delivery systems for aminoglycosides
      • 5.1.3.2. Research and development into aminoglycoside resistance mechanisms
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and toxicity caused due to aminoglycosides
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide utilization of gentamicin to treat infections in the blood, abdomen, lungs, skin, and soft tissues
    • 5.2.2. Application: Employment of aminoglycosides across respiratory diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aminoglycosides Market, by Product

  • 6.1. Introduction
  • 6.2. Amikacin
  • 6.3. Gentamicin
  • 6.4. Kanamycin
  • 6.5. Neomycin
  • 6.6. Paromomycin
  • 6.7. Streptomycin
  • 6.8. Tobramycin

7. Aminoglycosides Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectables
  • 7.3. Oral
  • 7.4. Topical

8. Aminoglycosides Market, by Application

  • 8.1. Introduction
  • 8.2. Respiratory Diseases
  • 8.3. Skin Infection
  • 8.4. UTI & Pelvic Diseases
  • 8.5. Veterinary Medicine

9. Americas Aminoglycosides Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aminoglycosides Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aminoglycosides Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Cipla Limited Unveils Plazomicin for Advanced Urinary Tract Infection Management in India
    • 12.3.2. Innovating Aminoglycoside Antibiotics for Enhanced Safety: Mitigating Hearing Loss Risks
    • 12.3.3. BDR Pharmaceuticals Launches Nilotinib: A Novel Approach in the Treatment of Rare Childhood and Adult Leukemia
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AstraZeneca plc
  • 3. Bristol Myers Squibb Company
  • 4. Cipla Limited
  • 5. GlaxoSmithKline plc
  • 6. Hangzhou Uniwise International Co., Ltd.
  • 7. HuvePharma
  • 8. Insmed Incorporated
  • 9. Jiangxi Bolai Pharmacy Co., Ltd.
  • 10. Kremoint Pharma Pvt. Ltd
  • 11. Medico Remedies Pvt. Ltd.
  • 12. Medson Pharmaceuticals
  • 13. Novartis AG
  • 14. Pfizer Inc.
  • 15. Teva Pharmaceutical Industries Ltd
  • 16. Vega Pharma Ltd.
  • 17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. AMINOGLYCOSIDES MARKET RESEARCH PROCESS
  • FIGURE 2. AMINOGLYCOSIDES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AMINOGLYCOSIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AMINOGLYCOSIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PAROMOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY UTI & PELVIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2023